NBTY to Webcast Presentation at Bank of America Merrill Lynch Health Care Conference; Announces Preliminary Unaudited Net Sales Results for April 2010

Tuesday, May 11, 2010 General News J E 4

RONKONKOMA, N.Y., May 11 NBTY, Inc. (NYSE: NTY) (, a leading global manufacturer and marketer of nutritional supplements, today announced that it will webcast the presentation by Harvey Kamil, President and Chief Financial Officer of NBTY, at the Bank of America Merrill Lynch Health Care Conference on Thursday, May 13, 2010.

The presentation is scheduled to be web cast live on the Company Web site,, on Thursday, May 13, 2010 at 8:00 AM (ET).

NBTY's preliminary unaudited net sales results for April 2010 by segment are as follows:

North American Retail same store sales increased 2% for the one month period. European Retail net sales in local currency, (British Pound Sterling), increased 3% and same store sales decreased 1%.


NBTY is a leading global vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the world. Under a number of NBTY and third party brands, the Company offers over 25,000 products, including products marketed by the Company's Nature's Bounty(R) (, Vitamin World(R) (, Puritan's Pride(R) (, Holland & Barrett(R) (, Rexall(R) (, Sundown(R) (, MET-Rx(R) (, Worldwide Sport Nutrition(R) (, American Health(R) (, GNC (UK)(R) (, DeTuinen(R) (, LeNaturiste(TM) (, SISU(R) (, Solgar(R) (, Good 'n' Natural(R) (, Home Health(TM) (, Julian Graves, ( and Ester-C(R), ( brands. NBTY routinely posts information that may be important to investors on its web site.

NET SALES (Preliminary and Unaudited) FOR THE MONTH OF APRIL ($ In Millions) % Change 2010 2009 -------- ---- ---- Wholesale / US Nutrition $139 $132 6% North American Retail $18 $17 3% European Retail $51 $48 7% Direct Response / E-Commerce $18 $17 7% --- --- --- Total $227 $214 6% ==== ==== ===



You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
MAP Pharmaceuticals Provides Update on Progress of...
Biomatrica Launches New Partnership Program - Biom...